CD155 is a crucial cell adhesion molecule that plays a significant role in cancer progression by regulating signaling pathways related to cell proliferation, migration, invasion, and adhesion.[107, 108] CD155 interacts with the TIGIT receptor on immune cells, leading to inhibition of the T‐cell‐ or natural‐killer‐cell‐mediated immune response. Here, PVR is linked to cancer.